Management of ceritinib therapy and adverse events in patients with ALK-rearranged non-small cell lung cancer. (Q38609692)
Jump to navigation
Jump to search
scientific article published on 09 June 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Management of ceritinib therapy and adverse events in patients with ALK-rearranged non-small cell lung cancer. |
scientific article published on 09 June 2017 |
Statements
Management of ceritinib therapy and adverse events in patients with ALK-rearranged non-small cell lung cancer (English)
Rohit Lal